We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.27%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.42B
AUM Growth
-$119M
(-4.7%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
11.89%
Holding
424
New
35
Increased
125
Reduced
216
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$22.3M |
| 2 |
AES
AES
|
+$14M |
| 3 |
SNV
Synovus
SNV
|
+$13.3M |
| 4 |
Delta Air Lines
DAL
|
+$12.8M |
| 5 |
Albemarle
ALB
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$21.4M |
| 2 |
Cisco
CSCO
|
+$18.9M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.4M |
| 4 |
HP
HPQ
|
+$13.9M |
| 5 |
GSK
GSK
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.35% |
| 2 | Industrials | 15.2% |
| 3 | Technology | 9.4% |
| 4 | Healthcare | 8.25% |
| 5 | Consumer Discretionary | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$918B
| $44.7M | 1.84% |
379,599
-25,650
| -6% | -$2.9M |
|
2
Citigroup
C
$223B
| $39.2M | 1.62% |
567,918
-38,175
| -6% | -$2.6M |
|
3
AT&T
T
$153B
| $33.3M | 1.37% |
1,165,517
-270,838
| -19% | -$7.18M |
|
4
Pfizer
PFE
$142B
| $32.8M | 1.35% |
961,514
+255,796
| +36% | +$9.3M |
|
5
Verizon
VZ
$181B
| $27.2M | 1.12% |
451,250
-30,200
| -6% | -$1.74M |
|
6
LXP Industrial Trust
LXP
$3.59B
| $23.1M | 0.95% |
450,614
+50,864
| +13% | +$2.54M |
|
7
Philip Morris
PM
$297B
| $22.8M | 0.94% |
299,960
-20,150
| -6% | -$1.6M |
|
8
BP
BP
$109B
| $22M | 0.91% |
578,770
-49,565
| -8% | -$1.89M |
|
9
CVS Health
CVS
$139B
| $21.7M | 0.89% |
343,721
+65,940
| +24% | +$3.91M |
|
|
RDS.B
10
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $21.5M | 0.89% |
359,705
-23,825
| -6% | -$1.42M |
|
11
Exelon
EXC
$46.9B
| $21.2M | 0.88% |
616,239
-259,370
| -30% | -$8.71M |
|
12
Old National Bancorp
ONB
$10.1B
| $21M | 0.87% |
1,222,193
-313,622
| -20% | -$5.35M |
|
13
KBR
KBR
$4.4B
| $20.7M | 0.85% |
844,579
+89,291
| +12% | +$2.27M |
|
14
Portland General Electric
POR
$6.03B
| $20.6M | 0.85% |
365,385
+10,327
| +3% | +$575K |
|
15
Tyson Foods
TSN
$20.2B
| $20.5M | 0.85% |
238,290
-15,996
| -6% | -$1.36M |
|
16
Citizens Financial Group
CFG
$30.3B
| $20.5M | 0.84% |
578,450
-38,575
| -6% | -$1.35M |
|
|
17
Johnson & Johnson
JNJ
$603B
| $20.4M | 0.84% |
157,598
-124,710
| -44% | -$16.4M |
|
18
Emcor
EME
$33.7B
| $20.2M | 0.83% |
234,867
-10,765
| -4% | -$916K |
|
19
UFP Industries
UFPI
$4.78B
| $20.2M | 0.83% |
506,368
+24,390
| +5% | +$949K |
|
|
20
Altria Group
MO
$123B
| $19.8M | 0.82% |
+484,800
| New | +$22.3M |
|
21
RTX Corp
RTX
$265B
| $19.8M | 0.82% |
230,786
+56,199
| +32% | +$4.67M |
|
22
Hancock Whitney
HWC
$6.25B
| $19.7M | 0.81% |
514,237
-92,467
| -15% | -$3.52M |
|
23
AllianceBernstein
AB
$3.54B
| $19.4M | 0.8% |
662,472
+54,934
| +9% | +$1.6M |
|
|
PPL
24
PPL Corp
PPL
$26.6B
| $19.1M | 0.79% |
605,396
-40,915
| -6% | -$1.24M |
|
|
BDN
25
Brandywine Realty Trust
BDN
$545M
| $18.4M | 0.76% |
1,217,124
+124,709
| +11% | +$1.82M |
|
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Foundry Partners held 424 positions worth $2.42B, down 4.7% from $2.54B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Foundry Partners withdrew a net $116M in Q3 2019, closing 37 positions and reducing 216 holdings. Its most notable exit was Allergan plc, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.
Against the trend, Foundry Partners opened a new position in Altria Group worth $19.8M.
- Foundry Partners's largest Q3 2019 buy was Altria Group: 484,800 shares worth $19.8M.
- Foundry Partners added most to Gilead Sciences in Q3 2019, an estimated $11.6M increase.
- Foundry Partners's biggest Q3 2019 reduction was Cisco, cutting an estimated $18.9M.
- Foundry Partners fully exited Allergan plc in Q3 2019, selling an estimated $21.4M.
- Foundry Partners's ten largest holdings make up 12% of its $2.42B portfolio in Q3 2019.
- Foundry Partners opened 35 new positions and closed 37 in Q3 2019.
- Foundry Partners's portfolio value fell 4.7% quarter-over-quarter to $2.42B.
Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.